» Articles » PMID: 19110618

Genetic Modification of Human Hematopoietic Cells: Preclinical Optimization of Oncoretroviral-mediated Gene Transfer for Clinical Trials

Overview
Specialty Molecular Biology
Date 2008 Dec 27
PMID 19110618
Authors
Affiliations
Soon will be listed here.
Abstract

This chapter provides information about the oncoretroviral transduction of human hematopoietic stem/ progenitor cells under clinically applicable conditions. We describe in detail a short -60 h transduction protocol which consistently yields transduction efficiencies in the range of 30-50% with five different oncoretroviral vectors. We discuss a number of parameters that affect transduction efficiency, including the oncoretroviral vector characteristics, the vector stock collection, the source of CD34+ cells and transduction conditions.

References
1.
Veena P, Traycoff C, Williams D, McMahel J, Rice S, Cornetta K . Delayed targeting of cytokine-nonresponsive human bone marrow CD34(+) cells with retrovirus-mediated gene transfer enhances transduction efficiency and long-term expression of transduced genes. Blood. 1998; 91(10):3693-701. View

2.
Deola S, Scaramuzza S, Birolo R, Carballido-Perrig N, Ficara F, Mocchetti C . Mobilized blood CD34+ cells transduced and selected with a clinically applicable protocol reconstitute lymphopoiesis in SCID-Hu mice. Hum Gene Ther. 2004; 15(3):305-11. DOI: 10.1089/104303404322886156. View

3.
Gaspar H, Parsley K, Howe S, King D, Gilmour K, Sinclair J . Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet. 2004; 364(9452):2181-7. DOI: 10.1016/S0140-6736(04)17590-9. View

4.
Lu L, Xiao M, Clapp D, Li Z, Broxmeyer H . High efficiency retroviral mediated gene transduction into single isolated immature and replatable CD34(3+) hematopoietic stem/progenitor cells from human umbilical cord blood. J Exp Med. 1993; 178(6):2089-96. PMC: 2191297. DOI: 10.1084/jem.178.6.2089. View

5.
Sanyal A, Schuening F . Increased gene transfer into human cord blood cells by centrifugation-enhanced transduction in fibronectin fragment-coated tubes. Hum Gene Ther. 1999; 10(17):2859-68. DOI: 10.1089/10430349950016582. View